• SCAI 2014 Late-Breaking Clinical Trials Selected

    Amid five tracks of in-depth "best of the best" education in invasive/interventional cardiology and record number of abstracts, SCAI 2014 Scientific Sessions will feature the following late-breaking clinical trials to be presented on Friday, May 30 from 2-3 PM PT:

    3-Dimensional Quantitative Coronary Angiography Using Coronary Catheters as Objective Markers Reliably Unmasks Severe Occult Stenosis in Diffusely Diseased Vessels: New Results from the IQ-CATEGORIZE Lesions Study
    Presented by Charles Laham, MD, FSCAI

     

    Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: ORBIT II 1-Year Results and Cost Comparison to a Sample of Medicare Hospital Claims
    Presented by Jeffrey Chambers, MD, FSCAI

     

    Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization: The Radiation Reduction during Cardiac Catheterization Using Real Time Monitoring (RadiCure) Study
    Presented by Georgios Christopoulos, MD

     

    Comparison of Lesion Level Decision Making in the Cath Lab Using Hyperemic and Non-Hyperemic Pressure Wire Derived Indices of Stenosis Severity: The VERIFY-2 Study
    Presented by Stuart Watkins, MD

     

  • Acknowledgements

    SCAI gratefully acknowledges the following companies for their generous support of the SCAI 2014 Scientific Sessions through educational grants while taking sole responsibility for all content developed and disseminated through this event.


    Platinum Sponsors

    • Abbott Vascular
    • Boston Scientific

    Silver Sponsors

    • AstraZeneca
    • Medtronic

    Bronze Sponsors

    • Cook Medical
    • Cordis, a Johnson & Johnson Company
    • Covidien
    • Gilead Sciences
    • St. Jude Medical
    • Terumo Interventional Systems


    SCAI also appreciates the educational grant support provided by Spectranetics.